(Bloomberg) -- Bausch + Lomb Corp., the maker of contact lenses and eye-care products, filed to go public in the U.S. and Canada through an initial public offering.
The unit of Bausch Health Co. said in a filing Thursday it would seek to raise $100 million, a placeholder amount that'll likely change. Morgan Stanley and Goldman Sachs Group Inc. are advising on the listing.
The listing will involve only existing shares and no new shares will be offered, according to the filing.
Founded in 1853 by John Jacob Bausch and Henry Lomb in Rochester, New York, the optical products maker reported $2.8 billion in revenue in the nine months ended September 2021, up 12% from the same period a year ago, the document showed. Its net income shrunk to $131 million from $191 million.
Bausch + Lomb is seeking to list shares on both the New York and Toronto Stock Exchanges. It plans to float shares under the symbol BLCO.
©2022 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
